HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SCCP opinion on shampoo ingredient

This article was originally published in The Rose Sheet

Executive Summary

Shampoo and conditioner ingredient polidocanol is "of low toxicity and does not pose a risk to the health of the consumer when used up to 3% in leave-on and up to 4% in rinse-off cosmetic products," the EU's Scientific Committee on Consumer Products concludes after reviewing a dossier on the ingredient. The review was initiated upon request from the European Commission in August after a member state raised concern that the use of polidocanol - which has an anesthetic effect in cosmetics - would lead to the inability of skin to perceive signals of damage such as sunburn (1"The Rose Sheet" Sept. 3, 2007, p. 6). SCCP says the scientific evidence "does not confirm that assumed local-anaesthetic effect" and the substance's "presence in cosmetics and skin care products will not affect cutaneous sensation"...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015126

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel